Published in Obesity and Diabetes Week, December 1st, 2003
According to recent research from the United States, "Leptin treatment of ob/ob mice leads to weight loss appreciably greater than that in pair-fed mice. To test whether this 'extra' weight loss is mediated by leptin-induced alterations in nutrient partitioning, the effects in ob/ob mice of subcutaneous leptin infusion (500 ng/h for {{<=}}21 days) on adipocyte fatty acid uptake and transporter gene expression were examined."
"Mice were initially hyperinsulinemic (5.25±1.57 nmol/L)," said Xinqing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.